Enable your JavaScript to use Numstock


Numstock » AERI

AERI Stock Analysis

The latest metrics for Aerie Pharmaceuticals, Inc

Value

Metric Target Value
Price / Earnings Ratio < 12.0 -4.61
Price / Book Value Ratio < 1.5 7.03
Price / Sales Ratio < 2.0 22.08
PEG Ratio < 1.0 0.0
EV / EBITDA Ratio < 8.0 -5.04
Price / FCF Ratio Last Year < 15.0 -4.15
Price / FCF Ratio Last Quarter < 15.0 -22.21
Price / TBV Ratio Last Year < 0.7 4.39
Price / TBV Ratio Last Quarter < 0.7 6.88
Price / NCAV Ratio Last Year < 0.7 6.14
Price / NCAV Ratio Last Quarter < 0.7 14.15

Efficiency

Metric Target Value
ROE Last Year > 25.0% -128
ROE Last Quarter > 25.0% -27.11
ROA Last Year > 15.0% -81.59
ROA Last Quarter > 15.0% -20.14
ROTA Last Year > 20.0% -89.58
ROTA Last Quarter > 20.0% -19.68
ROIC Last Year > 20.0% -663.1
ROIC Last Quarter > 20.0% -78.46
ROCE Last Year > 20.0% -89.53
ROCE Last Quarter > 20.0% -25.13
Inventory Turnover Last Year > 4.0 2.69
Inventory Turnover Last Quarter > 4.0 0.63
Pre-tax Margin Last Year > 20.0% -1217
Pre-tax Margin Last Quarter > 20.0% -377
Accounts Payable Turnover Last Year > 3.0 2.19
Accounts Payable Turnover Last Quarter > 3.0 0.72
Accounts Receivable Turnover Last Year > 5.0 10.01
Accounts Receivable Turnover Last Quarter > 5.0 2.4

Health

Metric Target Value
Current Ratio Last Year > 1.5 4.34
Current Ratio Last Quarter > 1.5 3.03
Quick Ratio Last Year > 1.5 4.14
Quick Ratio Last Quarter > 1.5 2.83
Flow Ratio Last Year < 1.25 0.34
Flow Ratio Last Quarter < 1.25 0.88
Debt / Equity Ratio Last Year < 0.5 0.0
Debt / Equity Ratio Last Quarter < 0.5 0.0
Debt / EBITDA Ratio Last Year < 4.0 0.0
Debt / EBITDA Ratio Last Quarter < 4.0 0.0
Debt / NCAV Ratio Last Year < 2.0 0.0
Debt / NCAV Ratio Last Quarter < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Year < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Quarter < 2.0 0.0
Interest Coverage Ratio Ratio Last Year > 8.0 82.87
Interest Coverage Ratio Last Quarter > 8.0 29.55
FCF / Sales Ratio Last Year > 8.0% -760.5
FCF / Sales Ratio Last Quarter > 8.0% -244.1

Growth

Metric Target Value
Earnings Yield > 12% -21.7
Ebit Yield Last Year > 12% -24.06
Ebit Yield Last Quarter > 12% -4.67
FCF Yield Last Year > 10% -18.08
FCF Yield Last Quarter > 10% -3.8
Forward P/E to Trailing P/E Ratio > 1.1 0.0
Operating Cash Flow / EPS Ratio Last Year > 1.2 0.7
Operating Cash Flow / EPS Ratio Last Quarter > 1.2 0.16

Dividends

Metric Target Value
Dividend Yield > 2.0% 0.0
FCF / Dividends Paid Ratio Last Year > 2.5 0.0
FCF / Dividends Paid Ratio Last Quarter > 2.5 0.0
EPS / Dividends Paid Last Year > 2.5 0.0
EPS / Dividends Paid Last Quarter > 2.5 0.0
Payout Ratio < 40.0% 0.0

Ratings

Metric Target Value
Altman Z-score Last Year ≥ 3.5 -2.94
Altman Z-score Last Quarter ≥ 3.5 -2.04